Anogenital cancers testing in Malcesine

Find health labs to test for Anogenital cancers in Malcesine and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Test by Laboratorio Lifebrain

Via Giovanni XXIII, 18 38065 Mori (TN)

10.2 km

Unverified

See Details

Pap Smear by Synlab

Via Varesche, 45, 37010 Costermano sul Garda VR, Italia

12.6 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Piazzale Achille Leoni, 22 38068 Rovereto (TN)

14.3 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Giovanni Pascoli, 4 c/o JoLab 37013 Affi (VR)

14.7 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Damiano Chiesa, 19 38060 Villa Lagarina (TN)

15.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via 3 Novembre, 10 38060 Pomarolo (TN)

16 km

Unverified

See Details

Pap Smear by Synlab

Via Provinciale Collio, 77, 25079 Vobarno BS, Italia

17 km

Unverified

See Details

Pap Smear by Synlab

Vobarno, Lombardia, Italia

17 km

Unverified

See Details

Pap Smear by Synlab

Via Pietro da Salò, 64, 25087 Salò BS, Italia

17.1 km

Unverified

See Details

Pap Smear by Synlab

Via Valpolicella, 63, 37026 Pescantina VR, Italia

19.6 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.